Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 23|pp. 9715–9729
A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
Back to articleFigure 6(6 of 8)
100%
Figure 6
Figure 6.Risk score comparison in subsets of the clinical characteristics (gender, age at diagnosis, and AJCC pathological stage).